Researchers apply FOXO4-DRI to investigate its selective interference with the FOXO4-p53 interaction that maintains senescent cell survival. Pre-clinical observations in fibroblast and aged tissue models indicate induction of apoptosis specifically in senescent cells, with reduced SASP factor secretion and improved tissue function.
This retro-inverso peptide facilitates examination of senescence-targeted mechanisms, clearance of dysfunctional cells, and restoration of tissue homeostasis in aging and disease-associated research paradigms.
Scientific Overview of FOXO4-DRI Applications
Pre-clinical models demonstrate FOXO4-DRI’s engagement with senescence-related pathways:
- Selective disruption of FOXO4-p53 nuclear retention, leading to p53-mediated apoptosis in senescent cells without affecting healthy or proliferating cells. https://pubmed.ncbi.nlm.nih.gov/28318936/
- Clearance of senescent cell burden in liver, kidney, muscle, and other tissues in progeroid and naturally aged mouse models.
- Improvement in physical function, fur density, and wound healing capacity following senescent cell elimination in aged animals.
- Reduction of age-related epigenetic alterations and support for tissue rejuvenation in multi-organ systems.
- Suppression of SASP-associated inflammatory signaling in cellular senescence models.
- Examination of senolytic specificity and safety in models of age-related degenerative conditions.
For further insights into FOXO4-p53 interactions, senolytic peptides, and cellular aging mechanisms in pre-clinical research, refer to the Peptide Sciences or About Peptides sections.
Why Investigators Select National Science Labs FOXO4-DRI
National Science Labs manufactures FOXO4-DRI under stringent GMP-compliant protocols to ensure batch-to-batch consistency and reliability for pre-clinical experiments. Independent third-party testing verifies each lot for:
- Purity ≥99.9% by HPLC
- Structural identity confirmation via mass spectrometry (D-amino acid configuration)
- Complete Certificate of Analysis (CoA) documentation provided per batch
For Research Use Only. This product is supplied exclusively for in vitro and in vivo pre-clinical research by qualified investigators. Statements about this peptide have not been evaluated by the FDA.
Initiate Your FOXO4-DRI Research Protocol
Source high-purity FOXO4-DRI from current limited batches to ensure optimal stability and performance in senescence clearance and longevity studies.
